The University of Colorado School of Medicine’s Sickle Cell Treatment and Research Center entered its 50th year with a major research victory: An experimental gene therapy has been successful in curing a patient of sickle cell disease (SCD), which affects millions of people around the globe.
When Sarah Massena joined the Center for Surgical Innovation (CSI) as executive director in 2007, she saw the role as an ideal way to merge her interests in science and business.
Innovation Patient Care Community
With the FDA emergency approval of the COVID-19 vaccine from Pfizer last week and Moderna approval due any day, immunizations against the deadliest pandemic in the past 100 years will begin this week.
CPR
July 25, 2024
In Colorado and across the nation, emergency departments at pediatric hospitals are overflowing with kids who need intensive mental health treatment.
9News
July 23, 2024
A little more than a month after the Olympics wrap up, women triathletes will be heading to the south of France for another competition on the global stage.
Healthy Debate
July 18, 2024
In 1961, Yuri Gagarin became the first human in space. With every kilometre he ascended, he pushed the boundaries of human achievement and catalyzed a surge of interest in exploration, research, development – and medical innovation.
Medscape
July 18, 2024
Experts debating the pressing issue of how to prioritize patients in the increasingly common scenario of loss of access or insurance coverage for anti-obesity glucagon-like peptide 1 (GLP-1) receptor agonist drugs argued that comorbidities and obesity severity should strongly warrant continued coverage — while offering key strategies for getting and retaining approval from payers.
Kara Mason
